Mikros Systems (OTCMKTS:MKRS) and Thermo Fisher Scientific (NYSE:TMO) are both aerospace companies, but which is the superior investment? We will ...
Lilly Phase 3 REACH-2 Trial Data Published in The Lancet Oncology Shows Improvement in Overall Survival with CYRAMZA® (ramucirumab) in Second-Line ...
Jim Cramer looks ahead at a busy week of earnings reports that he says might drive investors crazy.
Connected Wearable Patches Market Report offers a comprehensive study including company's products, applications and Forecast 2018 to 2025 of Connected ...
Mesa Laboratories (NASDAQ:MLAB) and Sypris Solutions (NASDAQ:SYPR) are both small-cap medical companies, but which is the better business? We will ...
Wall Street analysts expect NeoGenomics, Inc. (NASDAQ:NEO) to report $70.43 million in sales for the current quarter, according to Zacks Investment Research.
Cancer Genetics (CGIX) closed the Thursday at final price of $0.31 after traded 5463319 shares. The average volume was noted at 1082.98K shares while its ...
According to findings from the KEYNOTE-181 trial, pembrolizumab demonstrated a significant improvement in overall survival in patients with PD-L1–positive ...